Financials
- Market Capitalization 166.7 M
- Employee 59
- Founded 2018
- CEO N/A
- Website www.pepgen.com
- Headquarter Delaware, United States
- FIGI BBG012232618
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3749 | ALEC Alector, Inc. - Common Stock | 1.48 USD | -1.99% | -22.92% | -5.13% | -12.43% | 164.32 M USD | ||
| 3752 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.73 USD | +3.96% | +7.74% | -0.21% | +337.96% | 170.36 M USD | ||
| 3766 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.31 USD | +2.34% | +0.77% | +0.77% | -7.75% | 163.09 M USD | ||
| 3768 | MOLN Molecular Partners AG - American Depositary Shares | 4.00 USD | -0.25% | 0.00% | +3.90% | +10.50% | 161.50 M USD |